药物基因组学与高血压的个性化治疗

被引：2

作者：

徐蕙枫

罗明

机构：

[1] 同济大学附属同济医院心内科

来源：

国际心血管病杂志 | 2009年 / 36卷 / 06期

关键词：

抗高血压药; 药物基因组学; 基因; 单核苷酸多态性;

D O I：

暂无

中图分类号：

R544.1 [高血压];

学科分类号：

摘要：

不同个体对降压药物的治疗效果反应不同,多项研究发现基因多态性与不同个体对降压药物的反应之间存在一定联系。药物基因组学从基因水平研究多态性与药物效应多样性之间的关系,从而推动个性化用药,提高用药的安全性和有效性。文章介绍临床常用降压药与基因多态性的关系,预测药物基因组学在高血压个性化治疗中的前景。

引用

页码：385 / 388

页数：4

共 9 条

[1] 内皮型一氧化氮合酶基因T786C多态性与缬沙坦降压疗效的关系 [J].

华琦 ;

李东宝 ;

皮林 ;

陈海翎 .

高血压杂志, 2004, (04) :53-56

[2]

α-Adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: Results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES)[J] . Tobias Gerhard,Yan Gong,Amber L. Beitelshees,Xianyun Mao,Maximilian T. Lobmeyer,Rhonda M. Cooper-DeHoff,Taimour Y. Langaee,Nicholas J. Schork,Mark D. Shriver,Carl J. Pepine,Julie A. Johnson.American Heart Journal . 2008 (2)

[3] Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and anti hypertensive therapy [J].

Schelleman, H ;

Klungel, OH ;

van Duijn, CM ;

Witteman, JCM ;

Hofman, A ;

de Boer, A ;

Stricker, BHC .

ANNALS OF PHARMACOTHERAPY, 2006, 40 (02) :212-218

[4]

β1-Adrenergic receptor polymorphisms and left ventricular remodeling changes in response to β-blocker therapy[J] . Steven G. Terra,Karen K. Hamilton,Daniel F. Pauly,Craig R. Lee,J. Herbert Patterson,Kirkwood F. Adams,Richard S. Schofield,Bernadette S. Belgado,James A. Hill,Juan M. Aranda,Hossein N. Yarandi,Julie A. Johnson.Pharmacogenetics and Genomics . 2005 (4)

[5]

Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients[J] . Joshua C. Bis,Nicholas L. Smith,Bruce M. Psaty,Susan R. Heckbert,Karen L. Edwards,Rozenn N. Lemaitre,Thomas Lumley,Frits R. Rosendaal.American Journal of Hypertension . 2003 (12)

[6]

Variants of the CYP11B2 gene predict response to therapy with candesartan[J] . Jan R Ortlepp,Peter Hanrath,Vera Mevissen,Gerhard Kiel,Martin Borggrefe,Rainer Hoffmann.European Journal of Pharmacology . 2002 (1)

[7]

Predicting Response to Chronic Antihypertensive Treatment with Fosinopril: The Role of Angiotensin-Converting Enzyme Gene Polymorphism[J] . George A. Stavroulakis,Thomas K. Makris,Panagiota G. Krespi,Antonios N. Hatzizacharias,Argyri E. Gialeraki,George Anastasiadis,Philippos Triposkiadis,Michael Kyriakidis.Cardiovascular Drugs and Therapy . 2000 (4)

[8] Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension [J].